Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
412,914,375
-
Total 13F shares
-
3,731,679
-
Share change
-
-433,044
-
Total reported value
-
$4,067,948
-
Price per share
-
$1.09
-
Number of holders
-
17
-
Value change
-
-$471,792
-
Number of buys
-
8
-
Number of sells
-
3
Institutional Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q1 2025
As of 31 Mar 2025,
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) was held by
17 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,731,679 shares.
The largest 10 holders included
ORBIMED ADVISORS LLC, SPHERA FUNDS MANAGEMENT LTD., Yelin Lapidot Holdings Management Ltd., Ikarian Capital, LLC, MORGAN STANLEY, KESTRA PRIVATE WEALTH SERVICES, LLC, Virtu Financial LLC, BOOTHBAY FUND MANAGEMENT, LLC, RHUMBLINE ADVISERS, and TWO SIGMA SECURITIES, LLC.
This page lists
17
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.